Persbericht

11/01/2024 FSMA - HALFJAARLIJKS DASHBOARD OVER FRAUDE (11.01.2024)
11/01/2024 Ontex - breidt assortiment babybroekjes uit om aan de groeiende marktvraag te voldoen (11.01.2024)
11/01/2024 Recticel - rondt de overname af van REX (11.01.2024)
10/01/2024 TotalEnergies - increases its interests in offshore blocks 2913B and 2912 in Namibia (10.01.2023)
10/01/2024 Leleux Associated Brokers - stelt haar 20 aandelen voor 2024 voor (10.01.2024)
09/01/2024 FSMA - Minnelijke schikking met UnifiedPost Group S.A. (09.01.2024)
09/01/2024 BioSenic - signs a new subscription agreement for a maximum of EUR 1.2M in convertible bonds (09.01.2024)
09/01/2024 KBC - oefent call uit voor Additional Tier-1 (AT1) effecten uitgegeven in 2019 (09.01.2024)
09/01/2024 TOMTOM - TomTom Orbis Maps sets new standard for mapmaking with unprecedented coverage and visualization (09.01.2024)
09/01/2024 THERAVET - Agreement with Alcyon Italia for the distribution of BIOCERA-VET® product line in Italy (09.01.2024)
09/01/2024 MDxHealth - Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance (09.01.2024)
08/01/2024 KBC - speelt met aangepast rekeningaanbod in op veranderend klantengedrag (08.01.2024)
08/01/2024 UCB- announces European Commission approval of RYSTIGGO (rozanolixizumab) for the treatment of adults with generalized myasthenia gravis in Europe (08.01.2024)
05/01/2024 Ackermans & van Haaren - investeert in Vico Therapeutics (05.01.2024)
04/01/2024 Quest for Growth - NAV per aandeel op 31/12/2023: €7,51 (04.01.2024)
04/01/2024 Aedifica - investeert 8,5 miljoen € in 2 zorglocaties in Finland (04.01.2024)
04/01/2024 TotalEnergies - Entrusts Lionel Zinsou with a Mission to Assess the Land Acquisition Program (04.01.2024)
04/01/2024 TheraVet - reports significant success of its last educational webinar on canine osteosarcoma co-organized with Veterinary Instrumentation (04.01.2024)
04/01/2024 TotalEnergies - Closes its Deals with Alimentation Couche-Tard for €3.4 billion (04.01.2024)
04/01/2024 Galapagos - gaat een strategische samenwerking aan met BridGene Biosciences om de ontdekking van kleine moleculegeneesmiddelen in oncologie uit te breiden (04.01.2024)